Home / Inspections / 1262041

FDA Inspection 1262041 — Vaughn, Silverberg and Associates, LLP

Vaughn, Silverberg and Associates, LLP — FEI 3003724356

The FDA completed an inspection of Vaughn, Silverberg and Associates, LLP on February 19, 2025 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 19, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Austin, TX (United States)

Facility

Other inspections at this facility

  • 1149752 (NAI Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1049715 (NAI Thu Mar 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 887828 (NAI Sat Jul 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 773428 (NAI Thu Mar 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 541693 (NAI Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources